ACTION AND BINDING OF THE ENDOTHELIN ANTAGONIST BOSENTAN ON ASTROCYTES OF CULTURED RAT CENTRAL-NERVOUS-SYSTEM - ELECTROPHYSIOLOGICAL AND AUTORADIOGRAPHIC STUDIES
E. Hosli et al., ACTION AND BINDING OF THE ENDOTHELIN ANTAGONIST BOSENTAN ON ASTROCYTES OF CULTURED RAT CENTRAL-NERVOUS-SYSTEM - ELECTROPHYSIOLOGICAL AND AUTORADIOGRAPHIC STUDIES, Regulatory peptides, 66(3), 1996, pp. 149-153
Our autoradiographic studies demonstrate that astrocytes in explant cu
ltures of rat central nervous system possess binding sites for the fir
st orally active, mixed, nonpeptide endothelin receptor antagonist [H-
3]bosentan. Binding of [H-3]bosentan was inhibited by unlabelled bosen
tan and endothelin-l at high concentrations, suggesting specific bindi
ng of the antagonist. Electrophysiological studies have revealed that
bosentan reversibly blocked the depolarizations by endothelin but not
by angiotensin II, indicating that the antagonist specifically antagon
izes the action of endothelin on the glial membrane. This is consisten
t with biochemical studies from other laboratories demonstrating that
bosentan did not interfere with binding of angiotensin II. The availab
ility of bosentan, a potent and selective endothelin receptor antagoni
st should help to elucidate the role of endothelin on astrocyte functi
on.